Toxicity of non-A beta component of Alzheimer's disease amyloid, and N-terminal fragments thereof, correlates to formation of beta-sheet structure and fibrils
Am. Bodles et al., Toxicity of non-A beta component of Alzheimer's disease amyloid, and N-terminal fragments thereof, correlates to formation of beta-sheet structure and fibrils, EUR J BIOCH, 267(8), 2000, pp. 2186-2194
The non-A beta component of Alzheimer's disease amyloid (NAC) and its precu
rsor alpha-synuclein have been linked to amyloidogenesis in Alzheimer's dis
ease (AD), Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Pr
eviously we have shown that NAC forms beta-sheet structures and fibrils [El
-Agnaf, O.M.A., Bodles, A.M., Guthrie, D.J.S., Harriott, P. & Irvine, G.B.
(1998) Eur. J. Biochem. 258, 157-163]. As a measure of their neurotoxic pot
ential we have examined the ability of fresh and aged NAC and fragments the
reof to inhibit the reduction of the redox dye 3-(4,5-dimethylthiazol-2-yl)
-2,5 diphenyltetrazolium bromide by rat pheochromocytoma PC12 cells. Microm
olar concentrations of NAC and fragments thereof display varying degrees of
toxicity. On immediate dissolution and after an incubation period for 3 da
ys at 37 degrees C the full-length peptide and fragments NAC(3-18) and NAC(
1-18) scrambled sequence [NAC(1-18 s)] were toxic, whereas fragments NAC(1-
13) and NAC(6-14) were not. CD indicates that NAC(3-18) and NAC(1-18 s) exh
ibit beta-sheet secondary structure in aqueous solution, whereas NAC(1-13)
and NAC(6-14) do not. NAC(3-18) aggregates, as indicated by concentration o
f peptide remaining in solution after 3 days measured by an HPLC assay, and
forms fibrils, as determined by electron microscopy. However, although som
e fibrils were detected for NAC(1-18 s) it does not come out of solution to
a significant degree. Fragments NAC(1-13) and NAC(6-14) form few fibrils a
nd remain in solution. These findings indicate that the ability of the cent
ral region of NAC to form beta-sheet secondary structures is important for
determining the toxicity of the peptide. This contrasts with what has been
reported previously for most A beta peptides as their toxicity appears to r
equire the peptide to have formed fibrillary aggregates as well as displayi
ng beta-sheet. These results suggest that an intermediate, which exhibits b
eta-sheet structure, may be responsible for the toxic properties of NAC and
provides further evidence for the role of NAC in the pathogenesis of AD, P
D and DLB.